Results for “ ”

Entry Author Date Location
AstraZeneca Diabetes Drug Gets FDA OK for Reducing Heart Health Risks 05/06/20 National
Ventus Launches With $60M to Shine Light on Innate Immune System Drugs 05/06/20 Boston
Encouraging Signals for New Cancer Cell Therapy Strategies 05/06/20 National
Kura Narrows Pipeline After Strategic Review Prompted by COVID-19 05/05/20 San Diego
Alexion Pharma Boosts Blood Drug Lineup With $1.4B Deal for Portola 05/05/20 Boston
COVID-19 and Fungal Superinfections: The Deadly, Perfect Storm 05/05/20 San Diego
Stemline Slated for Acquisition by Menarini in Deal Worth Up to $677M 05/04/20 New York
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs 05/04/20 Boston
Pfizer Pays Valneva $130M for a Bite at a Lyme Disease Vaccine 05/01/20 Europe
FDA Authorizes “Emergency” Use of Gilead’s Remdesivir for Severe COVID-19 05/01/20 National
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses 05/01/20 Boston
Bio Roundup: Remdesivir Data, Erasca’s $200M, a New FDA Nod & More 05/01/20 National
Podcast: How San Diego is Building a Biotech Ecosystem – Genomics & Precision Medicine Experts Weigh in 04/30/20 National
BridgeBio’s Pipeline Expansion Continues as Portfolio’s Milestones Approach 04/30/20 San Francisco
Adicet Aims to Advance CAR-T Therapies in Reverse Merger with resTORbio 04/29/20 Boston
Supernus Makes a Parkinson’s Play With $300M Deal for US WorldMeds Drugs 04/29/20 National
Taysha Launches With $30M to Bring Gene Therapy to CNS Disorders 04/29/20 Texas
At Rome Therapeutics, Kapeller Aims to Turn “Junk” Into New Drugs 04/28/20 Boston
Neurocrine Gets FDA Nod for Once-Daily “Add-On” Parkinson’s Pill 04/27/20 San Diego
Erasca Lands $200M Mega-Round to Move Cancer Programs to the Clinic 04/27/20 San Diego
ADC Therapeutics Resubmits IPO to Fuel Cancer Drug Filing, Launch Plans 04/27/20 New York
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More 04/24/20 National
Drug Review Times Not Shortened Much by Single Expedited Review Designation 04/24/20 National
ORIC Pharma Gets $120M in IPO to Advance Drug-Resistant Cancer Therapies 04/24/20 San Francisco
Nitrome Bio Bags $38M to Prep Parkinson’s Program for the Clinic 04/23/20 San Francisco
Affinivax Lands $120M to Take MAPS Tech Into New Vaccine Territory 04/23/20 Boston
Life Science a VC Bright Spot in Q1, But Startups May Soon Struggle 04/23/20 National
Biogen Pushes Finalized Filing for Alzheimer’s Drug to Third Quarter 04/22/20 Boston
Immunomedics Triple Negative Breast Cancer Drug Wins Early FDA Nod 04/22/20 New York
Synthorx’s Shawver Joins Silverback Therapeutics as New Top Exec 04/22/20 Seattle
Page 3 of 1967 « previous page · next page »